SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,611.37 -43.23
( -0.06%)

Global Indices

Nasdaq

51,626.09 -1,142.23
(-2.16%)

Dow Jones

7,338.46 -111.32
(-1.49%)

Hang Seng

61,899.63 465.44
(0.76%)

Nikkei 225

10,896.96 25.94
(0.24%)

Forex

USD-INR

95.71 -0.26
(-0.27%)

EUR-INR

108.89 -0.40
(-0.37%)

GBP-INR

127.22 -0.62
(-0.49%)

JPY-INR

0.58 0.00
(-0.38%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

34.29

847.27

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.07

Back

mahindra & mahindra ltd

Taparia Tools standalone net profit rises 23.08% in the December 2025 quarter

Feb 10,2026

Net profit of Taparia Tools rose 23.08% to Rs 37.60 crore in the quarter ended December 2025 as against Rs 30.55 crore during the previous quarter ended December 2024. Sales rose 8.83% to Rs 255.63 crore in the quarter ended December 2025 as against Rs 234.90 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	255.63	234.90	9
OPM %	18.50	16.39	-
PBDT	50.29	41.36	22
PBT	49.54	40.64	22
NP	37.60	30.55	23

77,611.37 -43.23 ( -0.06%)

51,626.09 -1,142.23 (-2.16%)

7,338.46 -111.32 (-1.49%)

61,899.63 465.44 (0.76%)

10,896.96 25.94 (0.24%)

95.71 -0.26 (-0.27%)

108.89 -0.40 (-0.37%)

127.22 -0.62 (-0.49%)

0.58 0.00 (-0.38%)